Bio Essence Corporation
BIOE
$0.23
$0.0188.49%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -645.65% | 97.70% | -292.64% | -328.16% | 169.13% |
| Total Depreciation and Amortization | -66.67% | 200.00% | -66.67% | -40.00% | 101.65% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -11.54% | -98.73% | 471.14% | 183.04% | -515.87% |
| Change in Net Operating Assets | -61.84% | 33.47% | 210.19% | 325.32% | -9.65% |
| Cash from Operations | -106.17% | 18.48% | 2,233.99% | 108.92% | 15.92% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -3,267.27% | -102.88% | -42.44% |
| Total Debt Repaid | 28.84% | -197.82% | -50,433.33% | 96.91% | -125.33% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | 88.02% |
| Cash from Financing | 105.47% | -34.06% | -5,706.90% | -103.38% | -41.23% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 95.10% | -240.89% | 113.68% | -- | -100.00% |